First in Human, Dose Escalation, Dose Expansion Study of AUR105
Condition(s):Solid Tumor, Adult; Non-hodgkin Lymphoma; Hodgkin LymphomaLast Updated:January 31, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Solid Tumor, Adult; Non-hodgkin Lymphoma; Hodgkin LymphomaLast Updated:January 31, 2024Recruiting
Condition(s):Refractory Non-Hodgkin Lymphoma; Relapsed Non-Hodgkin LymphomaLast Updated:October 26, 2023Not yet recruiting
Condition(s):Smoking CessationLast Updated:April 10, 2023Completed
Condition(s):Symptomatic Aortic StenosisLast Updated:February 4, 2019Completed
Condition(s):Healthy; Frontotemporal DementiaLast Updated:July 27, 2020Completed
Condition(s):In-stent RestenosisLast Updated:February 16, 2023Active, not recruiting
Condition(s):Solid TumorLast Updated:February 8, 2024Terminated
Condition(s):Breast CancerLast Updated:October 13, 2023Recruiting
Condition(s):Atopic DermatitisLast Updated:June 18, 2023Completed
Condition(s):Idiopathic Pulmonary Fibrosis (IPF)Last Updated:July 19, 2022Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.